264 related articles for article (PubMed ID: 20701803)
1. An evolutionary analysis of cAMP-specific Phosphodiesterase 4 alternative splicing.
Johnson KR; Nicodemus-Johnson J; Danziger RS
BMC Evol Biol; 2010 Aug; 10():247. PubMed ID: 20701803
[TBL] [Abstract][Full Text] [Related]
2. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant.
Erdogan S; Houslay MD
Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of the human homologue of the short PDE4A cAMP-specific phosphodiesterase RD1 (PDE4A1) by analysis of the human HSPDE4A gene locus located at chromosome 19p13.2.
Sullivan M; Rena G; Begg F; Gordon L; Olsen AS; Houslay MD
Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):693-703. PubMed ID: 9677330
[TBL] [Abstract][Full Text] [Related]
4. PDE4B5, a novel, super-short, brain-specific cAMP phosphodiesterase-4 variant whose isoform-specifying N-terminal region is identical to that of cAMP phosphodiesterase-4D6 (PDE4D6).
Cheung YF; Kan Z; Garrett-Engele P; Gall I; Murdoch H; Baillie GS; Camargo LM; Johnson JM; Houslay MD; Castle JC
J Pharmacol Exp Ther; 2007 Aug; 322(2):600-9. PubMed ID: 17519386
[TBL] [Abstract][Full Text] [Related]
5. Splice variants of the cyclic nucleotide phosphodiesterase PDE4D are differentially expressed and regulated in rat tissue.
Richter W; Jin SL; Conti M
Biochem J; 2005 Jun; 388(Pt 3):803-11. PubMed ID: 15717866
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3.
Huston E; Lumb S; Russell A; Catterall C; Ross AH; Steele MR; Bolger GB; Perry MJ; Owens RJ; Houslay MD
Biochem J; 1997 Dec; 328 ( Pt 2)(Pt 2):549-58. PubMed ID: 9371714
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cAMP-specific phosphodiesterases type 4B and 4D (PDE4) splice variants by cAMP signaling in primary cortical neurons.
D'Sa C; Tolbert LM; Conti M; Duman RS
J Neurochem; 2002 May; 81(4):745-57. PubMed ID: 12065634
[TBL] [Abstract][Full Text] [Related]
8. Multiple splice variants of phosphodiesterase PDE4C cloned from human lung and testis.
Obernolte R; Ratzliff J; Baecker PA; Daniels DV; Zuppan P; Jarnagin K; Shelton ER
Biochim Biophys Acta; 1997 Sep; 1353(3):287-97. PubMed ID: 9349724
[TBL] [Abstract][Full Text] [Related]
9. Expression of mRNA encoding cAMP-specific phosphodiesterase isoforms in rat parotid glands.
Imai A; Nashida T; Shimomura H
Biochem Mol Biol Int; 1996 Dec; 40(6):1175-81. PubMed ID: 8988329
[TBL] [Abstract][Full Text] [Related]
10. Identification, characterization and regional distribution in brain of RPDE-6 (RNPDE4A5), a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family.
McPhee I; Pooley L; Lobban M; Bolger G; Houslay MD
Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):965-74. PubMed ID: 7575434
[TBL] [Abstract][Full Text] [Related]
11. Dimerization of the type 4 cAMP-specific phosphodiesterases is mediated by the upstream conserved regions (UCRs).
Richter W; Conti M
J Biol Chem; 2002 Oct; 277(43):40212-21. PubMed ID: 12177055
[TBL] [Abstract][Full Text] [Related]
12. Whole genome duplications and expansion of the vertebrate GATA transcription factor gene family.
Gillis WQ; St John J; Bowerman B; Schneider SQ
BMC Evol Biol; 2009 Aug; 9():207. PubMed ID: 19695090
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of PDE1 and PDE4 cyclic nucleotide phosphodiesterase isoforms in 7-oxo-prostacyclin-preconditioned rat heart.
Kostic MM; Erdogan S; Rena G; Borchert G; Hoch B; Bartel S; Scotland G; Huston E; Houslay MD; Krause EG
J Mol Cell Cardiol; 1997 Nov; 29(11):3135-46. PubMed ID: 9405187
[TBL] [Abstract][Full Text] [Related]
14. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454
[TBL] [Abstract][Full Text] [Related]
15. The upstream conserved regions (UCRs) mediate homo- and hetero-oligomerization of type 4 cyclic nucleotide phosphodiesterases (PDE4s).
Xie M; Blackman B; Scheitrum C; Mika D; Blanchard E; Lei T; Conti M; Richter W
Biochem J; 2014 May; 459(3):539-50. PubMed ID: 24555506
[TBL] [Abstract][Full Text] [Related]
16. Expression profiles of phosphodiesterase 4D splicing variants in osteoblastic cells.
Nomura-Furuwatari C; Wakitani S; Hashimoto Y; Imai Y; Ohta Y; Nakagawa K; Nakao Y; Takayama K; Manaka T; Takaoka K
J Bone Miner Metab; 2008; 26(2):152-8. PubMed ID: 18301971
[TBL] [Abstract][Full Text] [Related]
17. The oligomerization state determines regulatory properties and inhibitor sensitivity of type 4 cAMP-specific phosphodiesterases.
Richter W; Conti M
J Biol Chem; 2004 Jul; 279(29):30338-48. PubMed ID: 15131123
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase 4 and its inhibitors in inflammatory diseases.
Jin SL; Ding SL; Lin SC
Chang Gung Med J; 2012; 35(3):197-210. PubMed ID: 22735051
[TBL] [Abstract][Full Text] [Related]
19. Engineered stabilization and structural analysis of the autoinhibited conformation of PDE4.
Cedervall P; Aulabaugh A; Geoghegan KF; McLellan TJ; Pandit J
Proc Natl Acad Sci U S A; 2015 Mar; 112(12):E1414-22. PubMed ID: 25775568
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase-4 modulation as a potential therapeutic for cognitive loss in pathological and non-pathological aging: possibilities and pitfalls.
Hansen RT; Zhang HT
Curr Pharm Des; 2015; 21(3):291-302. PubMed ID: 25159075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
